Literature DB >> 18033035

[Lafora's disease presenting with progressive myoclonus epilepsy].

Y Béjot1, M Lemesle-Martin, F Contégal, A Graule-Petot, C Thauvin, M-H Aubriot-Lorton, T Moreau, M Giroud.   

Abstract

Lafora's disease is a progressive myoclonus epilepsy and must be evocated if myoclonus, occipital seizures and progressive cognitive impairment are present. We report the case of a 14-year-old boy who suffered from several occipital seizures and two generalised seizures. The diagnosis of Lafora's disease was made six years after these inaugural symptoms because of occurrence of myoclonus, aggravation of the epilepsy with paharmacoresistance and psychic deterioration. Axila sweat gland duct biopsy was performed to conclude to the disease. A mutation was found on the gene EPM2A. Lafora's disease is a genetic autosomal-recessive pathology. Two genes have been recently identified. They code for two proteins, malin and laforin, involved in glycogen metabolism in the cellular endoplasmic reticulum. Mutations of these genes are responsible for intracytoplasmic polyglucosan inclusions called Lafora bodies and pathognomonic of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033035     DOI: 10.1016/s0035-3787(07)92642-9

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.

Authors:  Luca Vignatelli; Francesca Bisulli; Federica Pondrelli; Lorenzo Muccioli; Laura Licchetta; Barbara Mostacci; Corrado Zenesini; Paolo Tinuper
Journal:  Orphanet J Rare Dis       Date:  2021-08-16       Impact factor: 4.123

2.  [When skin biopsy may label an epilepsy].

Authors:  Taoufiq Harmouch; Salim Gallouj; Kaoutar Znati; Aicha Slassi Sennou; Faouzi Belahcen; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2011-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.